reports
- ABGSC Metals & Mining Research
- Adrian Gilani
- Olof Cederholm
Star Shine Holdings Group Ltd: 1 director
A director at Star Shine Holdings Group Ltd sold 60,000,000 shares at 1.200HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
B.F. Holding S.p.A: 1 director
A director at B.F. Holding S.p.A bought 6,500 shares at 3.674EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Banco Santander SA: 1 director
A director at Banco Santander SA bought 345,248 shares at 4.570EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
Verkkokauppa.com Oyj: 1 director
A director at Verkkokauppa.com Oyj sold 280,000 shares at 2.200EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Allot Announces the Appointment of Eyal Harari as Chief Executive Offi...
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive Officer effective May 6, 2024. He will be replacing Mr. Erez Antebi. At the request of the company's Board of Directors, Mr. Antebi has agreed to assist Mr. Harari during a transition period and thereafter, to continue to provide co...
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Jay Skyler, MD, MACP, FRCP has been appointed to the company’s Board of Directors. “Dr. Skyler’s appointment to our Board of Directors is a major milestone for SAB,” said Samuel J. Reich, SAB’s chairman...
Flow Capital Announces Repayment of USD 4.5 Million Investment
Flow Capital Announces Repayment of USD 4.5 Million Investment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on providing flexible growth financing solutions to small and mid-cap high-growth companies across multiple sectors. With the help of our capital, companies are better able to execute their growth plans, scale their operations more aggres...
N2OFF: Save Foods to Target California’s Hemp Market
N2OFF: Save Foods to Target California’s Hemp Market More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp Neve Yarak, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- \ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to target the hemp flower market in California. The Company recently announced that the California Depar...
Skyward Specialty Announces Secondary Offering of Its Common Stock
Skyward Specialty Announces Secondary Offering of Its Common Stock HOUSTON, May 06, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”) market, announced that The Westaim Corporation (“Westaim”), through its wholly-owned subsidiary, Westaim HIIG GP Inc. (the “Selling Stockholder”) is offering 4,400,000 shares of the Company’s common stock in an underwritten secondary public offering. In connection with the offering, the Selling Stockholder has also granted the underwr...
- Research Department
ESTRATEGIA SEMANAL DE CRÉDITO: EL EMPLEO AMERICANO PONE TECHO AL TREAS...
Entorno: Los últimos datos de empleo americanos acercan la posibilidad de ver dos bajadas de tipos en EE.UU. este año, propiciando estrechamientos en la curva de deuda y devolviendo el apetito por el riesgo en los índices de crédito de beta alta. Para esta semana tendremos reunión del BoE (9 mayo). En EE.UU. pocas referencias durante la semana, apenas peticiones de empleo y confianza del consumidor preliminar de mayo. En la Eurozona conoceremos los PMI’s finales de abril, mientras que en Alemani...
Clariane : Modalités de mise à disposition et de consultation des info...
PARIS--(BUSINESS WIRE)-- Regulatory News: Clariane (CLARIA.PA – ISIN FR0010386334) (Paris:CLARI) informe ses actionnaires qu’une Assemblée générale mixte (l’« Assemblée générale ») de la Société se tiendra le lundi 10 juin 2024 à 10 heures à la salle Apostrophe, située 83 avenue Marceau, 750016 Paris. L’avis préalable de réunion comportant l’ordre du jour, le texte des projets de résolutions présentés par le Conseil d’administration ainsi que les modalités de participation et de vote à l’Assemblée générale a été publié au Bulletin des Annonces Légales Obligatoires n° 55 du 6 mai 2024. Le...
ALLETE Enters Agreement to be Acquired by a Partnership Led by Canada ...
DULUTH, Minn.--(BUSINESS WIRE)-- ALLETE, Inc. (NYSE: ALE) and a partnership led by Canada Pension Plan Investment Board (“CPP Investments”) and Global Infrastructure Partners (“GIP”), (the “partnership”), today jointly announced that they have entered into a definitive agreement under which the partnership will acquire ALLETE for $67.00 per share in cash, or $6.2 billion including the assumption of debt. ALLETE is a leading energy company and provider of safe, reliable, and competitively priced energy with a national footprint. Together, ALLETE and its family of companies, which includes reg...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region ...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in Algeria with the FIAT Professional brand Confirms market leadership in Europe 30 and South AmericaNorth America plays a key role in Pro One success; Ram announces new professional commercial vehicle divi...
AMG Reports Financial and Operating Results for the First Quarter of 2...
AMG Reports Financial and Operating Results for the First Quarter of 2024 Company reports EPS of $4.14, Economic EPS of $5.37 in first quarter Net Income (controlling interest) of $150 million, Economic Net Income (controlling interest) of $187 millionEconomic Earnings per share increased 28% year-over-year, reflecting strong business momentum and the positive impact of our capital allocation strategyIssued $450 million of 40-year junior hybrid debt and repurchased approximately $150 million in common stock WEST PALM BEACH, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AMG, a leading partner t...
Sanergy Group Limited: 1 director
A director at Sanergy Group Limited sold 78,000,000 shares at 2.580HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Anton Oilfield Services Group: 1 director
A director at Anton Oilfield Services Group sold 1,125,000 shares at 0.426HKD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Hi...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data demonstrating potential of a MYC-targeting epigenomic controller in NSCLC at AACR 2024Company to present new preclinical data demonstrating durable epigenomic upregulation and other OMEGA platform capabilities at ASGCT 2024 CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- O...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on ...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will report first quarter 2024 financial results on Monday, May 13, 2024, after the U.S. markets close. The press release will be available under “Press Releases” in the Investors section of the Company’s website at . About Cara Therapeutics Cara Therapeu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.